Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This Medical News article discusses an analysis of cardiovascular benefits and safety of semaglutide use in trial participants with frailty, defined by accumulated age-related health deficits.
Appeared: Sunday, November 1. JAMA. Peer-reviewed journal.